Literature DB >> 16948828

Parry-Romberg syndrome associated with borreliosis: could photochemotherapy halt the progression of the disease?

Emel Bulbul Baskan1, Seval Doğruk Kaçar, Ayşegül Turan, Hayriye Saricaoglu, Sukran Tunali, Saduman Balaban Adim.   

Abstract

Parry-Romberg syndrome (PRS) or progressive hemifacial atrophy is a rare entity characterized by unilateral atrophy of the skin, subcutaneous tissue and sometimes bone and cartilage. Although this syndrome has overlapping features of scleroderma 'en coup de sabre', it shows little or no sclerosis and may affect the entire distribution of the trigeminal nerve including the eye and tongue. As the pathogenesis is unknown, no effective therapy exists. We present here the third case of PRS associated with borreliosis and more interestingly two cases whose progressive course have been stabilized with gel PUVA therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16948828     DOI: 10.1111/j.1600-0781.2006.00238.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  4 in total

Review 1.  Progressive hemifacial atrophy: a review.

Authors:  Stanislav N Tolkachjov; Nirav G Patel; Megha M Tollefson
Journal:  Orphanet J Rare Dis       Date:  2015-04-01       Impact factor: 4.123

Review 2.  Oral manifestations of Parry-Romberg syndrome: A review of literature.

Authors:  Nader A Al-Aizari; Saleh Nasser Azzeghaiby; Hashem Motahir Al-Shamiri; Shourouk Darwish; Bassel Tarakji
Journal:  Avicenna J Med       Date:  2015 Apr-Jun

3.  The Chronic Encephalopathy of Parry Romberg Syndrome and En Coupe De Sabre with a 31-Year-History in a West Indian Woman: Clinical, Immunologic and Neuroimaging Abnormalities.

Authors:  Karan Seegobin; Kamille Abdool; Kanterpersad Ramcharan; Haramnauth Dyaanand; Fidel Rampersad
Journal:  Neurol Int       Date:  2016-09-30

Review 4.  Morphea - selected local treatment methods and their effectiveness.

Authors:  Joanna Narbutt; Agnieszka Hołdrowicz; Aleksandra Lesiak
Journal:  Reumatologia       Date:  2017-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.